IVD Raw Materials

A Global Strategic Business Report

MCP38974

RESEARCH DASHBOARD

NOV 2025

RELEASE DATE

7513

EXECUTIVE POOL

5850

PRICE

824

EXPERT INPUTS

39

COMPANIES

312

DATA TABLES

381

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global IVD Raw Materials Market to Reach US$35.8 Billion by 2030

The global market for IVD Raw Materials estimated at US$27.7 Billion in the year 2024, is expected to reach US$35.8 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. IVD Antibody & Antigens, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$13.0 Billion by the end of the analysis period. Growth in the IVD Enzymes segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.6 Billion While China is Forecast to Grow at 7.8% CAGR

The IVD Raw Materials market in the U.S. is estimated at US$7.6 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.3 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global IVD Raw Materials Market - Key Trends & Drivers Summarized

What Role Do Raw Materials Play in the Reliability of In Vitro Diagnostics?

IVD raw materials refer to the essential biological, chemical, and synthetic components used in the manufacture of in vitro diagnostic tests and kits. These include antibodies, antigens, enzymes, nucleotides, reagents, buffers, stabilizers, and control materials. The quality, consistency, and performance of these raw inputs directly impact the sensitivity, specificity, and reproducibility of diagnostic assays used for disease detection, monitoring, and screening.

Demand for reliable IVD raw materials has surged with the rise in molecular diagnostics, point-of-care testing, and infectious disease surveillance. Manufacturers are under pressure to source high-purity, lot-consistent raw materials to ensure regulatory compliance and assay reliability. Biotech firms and research labs also depend on IVD-grade materials for developing new test formats in oncology, cardiology, and infectious diseases.

What Innovations Are Transforming Material Sourcing and Quality Assurance?

Suppliers of IVD raw materials are investing in advanced purification processes, expression systems, and recombinant production technologies to meet stringent quality standards. Monoclonal antibody production, synthetic peptide synthesis, and enzyme engineering are being refined to deliver high-yield, reproducible batches. Recombinant antigens and nucleic acid probes are being used to replace variable biological materials in high-precision test kits.

Material suppliers are also offering pre-validated raw inputs with stability testing, performance documentation, and traceable lot records to streamline regulatory filings by IVD manufacturers. GMP-compliant manufacturing, ISO certifications, and global distribution capabilities are becoming prerequisites as test developers seek reliable, scalable, and audit-ready suppliers. Some companies are developing vertically integrated production lines to ensure uninterrupted supply during public health crises or demand surges.

Where Is Demand Concentrated, and Who Are the Leading Buyers?

Demand is strongest among diagnostic kit manufacturers, molecular test developers, and reference laboratories. Companies developing PCR-based diagnostics, ELISA kits, lateral flow assays, and sequencing platforms rely on a wide range of raw materials tailored to specific detection targets. Research organizations and biotech firms also purchase IVD-grade materials for assay development and clinical validation.

North America and Europe remain key markets due to the concentration of diagnostics firms and regulatory stringency. Asia Pacific is growing rapidly, driven by local manufacturing initiatives, expanding disease surveillance, and increasing export capacity. Public health laboratories, academic institutions, and contract diagnostic manufacturers are expanding their raw material usage as global diagnostic capacity grows.

What Is Driving Growth in the IVD Raw Materials Market?

Growth in the IVD raw materials market is driven by several factors including rising global demand for diagnostic testing, increasing complexity of assay formats, and heightened regulatory scrutiny of material quality. Advances in recombinant production, synthetic chemistry, and expression systems are enabling reliable, scalable supply of high-performance components.

End-use expansion in molecular diagnostics, infectious disease testing, and personalized medicine is creating recurring demand for highly specific and stable raw materials. Emergence of new pathogens, focus on decentralized testing, and growing investment in lab infrastructure are further boosting usage. As diagnostics become central to preventive and precision medicine, the need for high-quality IVD raw materials continues to grow in both established and emerging healthcare markets.

SCOPE OF STUDY

The report analyzes the IVD Raw Materials market by the following Segments, and Geographic Regions/Countries:

Segments:

Product (IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers, Other Products); Technology (Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology, Other Technologies); End-Use (Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use, Other End-Uses).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

Aalto Bio Reagents Ltd.; AMSBIO (AMS Biotechnology); BBI Solutions; Bio-Rad Laboratories, Inc.; Bio-Check (UK) Ltd; Bioporto Diagnostics; Diarect AG; EastCoast Bio; Fitzgerald Industries Intl.; Fujirebio; HyTest Ltd; Jena Bioscience GmbH; Medix Biochemica; Meridian Bioscience, Inc.; MyBiosource, Inc.; QuidelOrtho Corporation; RayBiotech, Inc.; Rockland Immunochemicals, Inc.; Scripps Laboratories, Inc.; Sekisui Diagnostics;

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

World Market Trajectories

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

IVD Raw Materials – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 39 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Demand for In Vitro Diagnostics Across Infectious Disease, Cancer, and Genetic Testing Drives Consumption of Raw Materials

Expansion of Point-of-Care and Home Diagnostics Strengthens Need for High-Quality Antibodies, Antigens, and Buffers

OEM Focus on Recombinant Protein Engineering and Monoclonal Antibody Production Enhances Specificity and Stability

Growth in Molecular Diagnostics and PCR-Based Assays Throws Spotlight on High-Fidelity Enzymes and Primers

Increasing Emphasis on Supply Chain Resilience and Material Traceability Supports Strategic Sourcing of IVD Inputs

OEM Investment in GMP-Compliant Raw Material Manufacturing Improves Quality Assurance for Diagnostic Kit Producers

Rising Adoption of Multiplex Assays and Rapid Diagnostic Tests Fuels Need for Custom Coating and Blocking Reagents

OEM Development of Bulk Supply Agreements With Test Kit Manufacturers Enhances Scalability and Delivery Reliability

Growth in Companion Diagnostics and Personalized Medicine Expands Use of Specialized Biomarker Reagents

OEM Innovation in Lyophilized and Room-Temperature Stable Raw Materials Supports Distribution in Low-Resource Settings

4. GLOBAL MARKET PERSPECTIVE

World IVD Raw Materials Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

World Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for IVD Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for IVD Antibody & Antigens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for IVD Antibody & Antigens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for IVD Antibody & Antigens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for IVD Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for IVD Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for IVD Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for IVD Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for IVD Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for IVD Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for IVD Biological Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for IVD Biological Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for IVD Biological Buffers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Clinical Chemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Immunochemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Immunochemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Immunochemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

USA Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

USA Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Canada Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Canada Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

JAPAN

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Japan Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Japan Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

CHINA

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

China Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

China Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

EUROPE

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe Historic Review for IVD Raw Materials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

FRANCE

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

France Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

France Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

GERMANY

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Germany Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Germany Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Italy Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Italy Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

UNITED KINGDOM

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

UK Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

UK Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Spain Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Spain Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Russia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Russia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

ASIA-PACIFIC

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for IVD Raw Materials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

AUSTRALIA

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Australia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Australia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

INDIA

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

India Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

India Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

LATIN AMERICA

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Latin America Historic Review for IVD Raw Materials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

MIDDLE EAST

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Middle East Historic Review for IVD Raw Materials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Iran Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Iran Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Israel Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Israel Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

UAE Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

UAE Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

AFRICA

IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030

Africa Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Africa Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll